1 Department of Pharmaceutical Health Services Research, 12265 University of Maryland School of Pharmacy, Baltimore, MD, USA.
2 Department of Epidemiology and Public Health, 12265 University of Maryland School of Medicine, Baltimore, MD, USA.
Lupus. 2018 Mar;27(3):475-483. doi: 10.1177/0961203317726375. Epub 2017 Aug 31.
Introduction The use of corticosteroids in systemic lupus erythematosus (SLE) patients requires difficult trade-offs between efficacy and risk of toxicity. This qualitative study examined SLE patients' most desired outcomes and their concerns with corticosteroid use in SLE treatment. Methods SLE patients with current/past experience with using corticosteroids were recruited from the clinics at the Johns Hopkins Lupus Center and the University of Maryland Medical Center. Five in-depth interviews ( N = 5) and four focus groups ( N = 15) were conducted during which discussions were transcribed and analyzed based on a grounded theory approach. Results We identified five major themes describing SLE patients' most desired outcomes: reduction in flares, maintenance of normal activities, minimization of treatment side effects, prevention of future organ damage, and finding a cure. Further, SLE patients reported these primary concerns with the adverse effects of corticosteroids: weight gain, organ damage (particularly bone-related damage), mood swings/irritability, sleep disturbances, and dental issues. Patients appeared to be more concerned with adverse effects that immediately affected their day-to-day lives. Conclusion Knowledge gained during this study better informs how patients view the benefits and risks of corticosteroids. This can facilitate discussions between physicians and patients as they work together to determine the appropriate use of corticosteroids.
介绍 系统性红斑狼疮 (SLE) 患者使用皮质类固醇需要在疗效和毒性风险之间进行艰难的权衡。这项定性研究探讨了 SLE 患者最希望达到的治疗结果以及他们对 SLE 治疗中皮质类固醇使用的担忧。 方法 从约翰霍普金斯狼疮中心和马里兰大学医学中心的诊所招募了目前/过去有皮质类固醇使用经验的 SLE 患者。共进行了 5 次深入访谈( N = 5)和 4 次焦点小组( N = 15),根据扎根理论方法对讨论进行转录和分析。 结果 我们确定了五个主要主题,描述了 SLE 患者最希望达到的治疗结果:减少发作、维持正常活动、最小化治疗副作用、预防未来器官损伤和寻找治愈方法。此外,SLE 患者报告了这些对皮质类固醇不良反应的主要担忧:体重增加、器官损伤(特别是与骨骼相关的损伤)、情绪波动/易怒、睡眠障碍和牙齿问题。患者似乎更担心那些立即影响日常生活的不良反应。 结论 本研究获得的知识更好地说明了患者如何看待皮质类固醇的益处和风险。这可以促进医生和患者之间的讨论,因为他们共同努力确定皮质类固醇的适当使用。